Amirfallah A, Knutsdottir H, Arason A, Hilmarsdottir B, Johannsson OT, Agnarsson BA et al (2021) Hsa-miR-21-3p associates with breastcancer patient survival and targets genes in tumorsuppressive pathways. PLoS One 16(11):e0260327. https://doi.org/10.1371/journal.pone.0260327

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anwar SL, Sari DNI, Kartika AI, Fitria MS, Tanjung DS, Rakhmina D, Wardana T, Astuti I, Haryana SM, Aryandono T (2019) Upregulation of circulating MiR-21 expression as a potential biomarker for therapeutic monitoring and clinical outcome in breast cancer. Asian Pac J Cancer Prev 20(4):1223–1228. https://doi.org/10.31557/APJCP.2019.20.4.1223

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashirbekov Y, Abaildayev A, Omarbayeva N, Botbayev D, Belkozhayev A, Askandirova A, Neupokoyeva A, Utegenova G, Sharipov K, Aitkhozhina N (2020) Combination of circulating miR-145-5p/miR-191-5p as biomarker for breast cancer detection. Peer J 16(8):e10494. https://doi.org/10.7717/peerj

Article  Google Scholar 

Cala MP, Aldana J, Medina J, Sanchez J, Guio J, Wist J et al (2018a) Multiplatformplasma metabolic and lipid fingerprinting of breast cancer: a pilotcontrol-case study in Colombian Hispanic women. PLoS One 13:e0190958

Article  PubMed  PubMed Central  Google Scholar 

Cala M, Aldana J, Sanchez J, Guio J, Meesters RJW (2018b) Urinary metabolite andlipid alterations in Colombian Hispanic women with breast cancer: a pilotstudy. J Pharm Biomed Anal 152:234–241

Article  CAS  PubMed  Google Scholar 

Cascino A, Muscaritoli M, Cangiano C et al (1995) Plasma amino acid imbalance in patients with lung and breast cancer. Anticancer Res 15(2):507–510

CAS  PubMed  Google Scholar 

Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA et al (2013) Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res 19:4477–4487

Article  CAS  PubMed  Google Scholar 

Coloff JL, Murphy JP, Braun CR, Harris IS, Shelton LM, Kami K et al (2016) Differential glutamate metabolism in proliferating and quiescent mammaryepithelial cells. Cell Metab 23:867–880

Article  CAS  PubMed  Google Scholar 

Ding Y, Zhang C, Zhang J, Zhang N, Li T, Fang J, Zhang Y, Zuo F, Tao Z, Tang S, Zhu W, Chen H, Sun X (2017) miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-β1 expression. Int J Oncol 50(5):1701–1710

Article  CAS  PubMed  Google Scholar 

Dowling P, Henry M, Meleady P, Clarke C, Gately K, O’Byrne K et al (2015) Metabolomic and proteomic analysis of breast cancer patient samples suggeststhat glutamate and 12-HETE in combination with CA15-3 may be usefulbiomarkers reflecting tumour burden. Metabolomics 11:620–635

Article  CAS  Google Scholar 

Ducret A, James I, Wilson S, Feilke M, Tebbe A, Dybowski N et al (2019) Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial. PLoS One 14(3):e0213892

Article  CAS  PubMed  PubMed Central  Google Scholar 

El Ansari R, McIntyre A, Craze ML, Ellis IO, Rakha EA, Green AR (2018) Alteredglutamine metabolism in breast cancer; subtype dependencies and alternativeadaptations. Histopathology 72:183–190

Article  PubMed  Google Scholar 

El-Daly SM, Morsy SM, Medhat D et al (2019) The diagnostic efficacy of circulating miRNAs in monitoring the early development of colitis-induced colorectal cancer. J Cell Biochem 120:16668–16680. https://doi.org/10.1002/jcb.28925

Article  CAS  PubMed  Google Scholar 

El-Daly SM, Bayraktar R, Anfossi S, Calin GA (2020) The Interplay between MicroRNAs and the components of the tumor microenvironment in B-cell malignancies. Int J Mol Sci 21(9):3387. https://doi.org/10.3390/ijms21093387

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Daly SM, Gouhar SA, Abd Elmageed ZY (2022) Circulating microRNAs as reliable tumor biomarkers: opportunities and challenges facing clinical application. J Pharmacol Exp Ther. https://doi.org/10.1124/jpet.121.000896

Article  PubMed  Google Scholar 

Elzoghby DMA, Mahmoud NH, Aly HH, Matar M (2019) Circulating microRNA-21 as a promising marker for early detection of breast cancer and disease progression in Egyptian females. Med J Cairo Univ 87:2491–2500. https://doi.org/10.21608/mjcu.2019.54858

Article  Google Scholar 

Eniu DT, Romanciuc F, Moraru C, Goidescu I, Eniu D, Staicu A et al (2019) Thedecrease of some serum free amino acids can predict breast cancer diagnosisand progression. Scand J Clin Lab Investig 79:17–24

Article  CAS  Google Scholar 

Escuin D, López-Vilaró L, Mora J, Bell O, Moral A, Perez I, Arqueros C, Garcia-Valdecasas B, Ramón y Cajal T, Lerma E, Barnadas A (2021) Circulating microRNAs in early breast cancer patients and its association with lymph node metastases. Front Oncol. https://doi.org/10.3389/fonc.2021.627811

Article  PubMed  PubMed Central  Google Scholar 

Feng YH, Tsao CJ (2016) Emerging role of microRNA-21 in cancer. Biomed Rep 5(4):395–402. https://doi.org/10.3892/br.2016.747

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng J, Qi B, Guo L, Chen LY, Wei XF, Liu YZ, Zhao BS (2017) miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma. World J Gastroenterol 23(23):4243–4251. https://doi.org/10.3748/wjg.v23.i23.4243

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferretti G, Felici A, Papaldo P, Fabi A, Cognetti F (2007) HER2/neu role in breast cancer: from a prognostic foe to a predictive friend. Curr Opin Obstet Gynecol 19(1):56–62. https://doi.org/10.1097/gco.0b013e328012980a

Article  PubMed  Google Scholar 

Fu L, Li Z, Zhu J, Wang P, Fan G, Dai Y, Zheng Z, Liu Y (2016) Serum expression levels of microRNA-382-3p, -598-3p, -1246 and -184 in breast cancer patients. Oncol Lett 12(1):269–274. https://doi.org/10.3892/ol.2016.4582

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao J, Zhang Q, Xu J, Guo L, Li X (2013) Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA. Chin J Cancer Res 25(6):743–748. https://doi.org/10.3978/j.issn.1000-9604.2013.12.04

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez-Villasana V, Rashed MH, Gonzalez-Cantú Y, Bayraktar R, Menchaca-Arredondo JL, Vazquez-Guillen JM, Rodriguez-Padilla C, Lopez-Berestein G, Resendez-Perez D (2019) Presence of Circulating miR-145, miR-155, and miR-382 in exosomes isolated from serum of breast cancer patients and healthy donors. Dis Mark 2019:6852917. https://doi.org/10.1155/2019/6852917

Article  CAS  Google Scholar 

Han JG, Jiang YD, Zhang CH, Yang YM, Pang D, Song YN, Zhang GQ (2017) A novel panel of serum miR-21/miR-155/miR-365 as a potential diag-nostic biomarker for breast cancer. Ann Surg Treat Res 92(2):55–66

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu J, Guo H, Li H, Liu Y, Liu J, Chen L, Zhang J, Zhang N (2012) MiR-145 regulates epithelial to mesenchymal transition of breast cancer cells by targeting Oct4. PLoS One 7(9):e45965. https://doi.org/10.1371/journal.pone.0045965

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ibrahim AM, Said MM, Hilal AM, Medhat AM, Abd Elsalam IM (2020) Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients. Tumor Biol. https://doi.org/10.1177/1010428320963811

Article  Google Scholar 

Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16):7065–7070. https://doi.org/10.1158/0008-5472.CAN-05-1783

Article  CAS  PubMed  Google Scholar 

Iqbal N, Iqbal N (2014) Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications. Mol Biol Int 2014:852748. https://doi.org/10.1155/2014/852748

Article  CAS  PubMed  PubMed Central  Google Scholar 

Itani MM, Nassar FJ, Tfayli AH, Talhouk RS, Chamandi GK, Itani ARS, Makoukji J, Boustany R-MN, Hou L, Zgheib NK, Nasr RR (2021) A signature of four circulating microRNAs as potential biomarkers for diagnosingEarly-stage breast cancer. Int J Mol Sci 22:6121. https://doi.org/10.3390/ijms22116121

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jang JY, Kim YS, Kang KN, Kim KH, Park YJ, Kim CW (2021) Multiple microRNAs as biomarkers for early breast cancer diagnosis. Mol Clin Oncol 14:31

Article  CAS  PubMed  Google Scholar 

Jurkovicova D, Smolkova B, Magyerkova M, Sestakova Z, Kajabova VH et al (2017) Down-regulation of traditional oncomiRs in plasma of breast cancer patients. Oncotarget 8(44):77369–77384

Article  PubMed  PubMed Central  Google Scholar 

Kim S-J, Oh J-S, Shin J-Y, Lee K-D, Sung KW, Nam SJ, Chun K-H (2011) Development of microRNA-145 for therapeutic application in breast cancer. J Contr Release 155:427–434. https://doi.org/10.1016/j.jconrel.2011.06.026

Article  CAS  Google Scholar 

Kimura T, Noguchi Y, Shikata N et al (2009) Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks. Curr Opin Clin Nutr Metab Care 12(1):49–53

Article  CAS  PubMed  Google Scholar 

Lange T, Stracke S, Rettig R et al (2017) Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients. PLoS One 12(8):e0183435. https://doi.org/10.1371/journal.pone.01834